ReviewExperientia supplementum (2012)2026
MicroRNAs as Biomarkers for the Diagnosis and Prognosis of Different Diseases and Cancer.
Review in Experientia supplementum (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Natural Products in Prostate Cancer: Crosstalk Among the Gut Microbiome, Androgen Receptor Signaling, and Epigenetic Regulation.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Small, endogenous noncoding RNAs known as miRNAs are widely distributed and use posttranscriptional control to suppress the expression of target genes. miRNAs have crucial roles in the development of disease and carcinogenesis, and new research suggests that miRNAs might be reliable diseases biomarkers. The identification of miRNAs in bodily fluids, in particular, has created a compelling possibility for the creation of noninvasive biomarkers for disease diagnosis, prognosis, and response prediction to treatment. Deregulation of the expression of microRNAs, which are essential for the regulation of several biological processes, has been connected to the emergence of metabolic, cardiovascular, neurodegenerative, and cancerous disorders. An exhaustive, up-to-date, and comprehensive investigation of the role of miRNAs in disease is presented in this chapter. Its goal is to stimulate further study in this field since small miRNAs may be utilized for effective disease detection, prognosis, and therapy.
Indexed as
Identifiers
41479115What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.